Evonik's superabsorbents business is sold! Only remaining intermediates business line in the High Performance Materials Division
Evonik has successfully sold its superabsorbents business to International Chemical Investment Group (ICIG).
The transaction was completed on August 31, 2024, subject to approval by the competition authorities. Superabsorbents are powdered polymers used as absorbent materials in diapers and other hygiene products.
The business unit has sales of 892 million euros in 2023, has about 1,000 employees, and has three offices in Germany and two in the United States.
The superabsorbents business is the second of three business lines in the High Performance Materials Division that Evonik has sold. After the Rülsdorf business (also sold to ICIG) and the superabsorbents business, only the High Performance Intermediates business line remains. Evonik is testing the market in preparation for a possible launch of the sales process.
"We want to clearly focus our portfolio on highly profitable, low-volatility businesses that drive the green transition of the economy. We remain committed to this path without losing sight of the well-being of our employees," said Christian Kullmann, Chairman of the Executive Board of Evonik.
ICIG is an experienced chemical investor headquartered in Frankfurt, Germany. Together with the superabsorbents business, the Group now has more than 7,800 employees at around 50 locations worldwide and annual sales of more than €4 billion.
"We are pleased to now have superabsorbents as a new platform for ICIG and warmly welcome all employees," said Dr. Achim Riemann, Chairman of the Supervisory Board of ICIG. "This acquisition is part of our expansion plans, which we will continue to achieve through both internal and external growth."
2026-10-23
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
BASF and Evonik Rumored Potential Acquisition or Merger
-
Evonik Expands Slovakian Fermas Site with €80 Million Investment to Boost Pharmaceutical CDMO Capacity
-
Evonik to Close Two German Plants, Further Cutting Europe’s High-Purity Silicon Tetrachloride Capacity
-
Multiple Chemical Industry Leaders Post Strong H1 Earnings Growth as Sector Profitability Revives
-
Evonik Inaugurates New Speciality Alumina Plant in Japan, Bolstering Regional Growth Strategy
-
Evonik and AMSilk Expand Collaboration to Develop Sustainable Biotech Silk Materials
-
Evonik Launches Asia’s First Alkoxide Plant in Jurong Island
-
Evonik Converts Epoxy Hardener Production to 100% Renewable Electricity
-
Breakup! Vland Biotech and Evonik Part Ways as GHS Joint Venture Falls Short of Expectations
-
Evonik Completes Shift to Green Electricity for Polybutadiene Production at its Marl, Germany, Plant
Recommend Reading
-
China’s Chemical Time Bomb Just Got a Legal Fuse: The New Law That Could Save Thousands of Lives
-
U.S. 10% Temporary Tariff Expires, New Section 301 Tariffs Not Yet Implemented
-
Profits Are Rising, but So Are the Risks—China’s Coatings Industry Is Living Through Its Most Awkward Year
-
This Is Not a Price Increase Wave but a Full-Blown Cost Squeeze Across China’s Coatings Chain
-
Retinol in Cosmetics: Regulatory Tightening and Market Changes
-
Strong Demand Drives Slight Rise in Toluene Market in November
-
End-of-Month Maleic Anhydride Market Trends Primarily Consolidating
-
China's Urea Market Fluctuates (11.21-11.28)
-
This Week's Acetic Acid Market Continues to Rise in China
-
Premium Global Chemical Sourcing Requests (22-26 Dec 2025)